Merck Vaccines
DashboardTherapeutic AreasVaccinesRegionsPlatformsSocial MediaNews & MediaAlertsAnalytics
Settings

Vaccines Sentiment Analysis

Monitor and analyze sentiment across Merck's vaccine portfolio

GARDASIL®9

Human Papillomavirus 9-valent Vaccine, Recombinant

Cancer Prevention
Negative Sentiment78%

M-M-R®II

Measles, Mumps, and Rubella Virus Vaccine Live

Pediatric
Negative Sentiment65%

PNEUMOVAX®23

Pneumococcal Vaccine Polyvalent

Respiratory
Negative Sentiment55%

VARIVAX®

Varicella Virus Vaccine Live

Pediatric
Negative Sentiment48%

RECOMBIVAX HB®

Hepatitis B Vaccine (Recombinant)

Infectious Disease
Negative Sentiment42%

VAQTA®

Hepatitis A Vaccine, Inactivated

Travel
Negative Sentiment38%

ROTATEQ®

Rotavirus Vaccine, Live, Oral, Pentavalent

Pediatric
Negative Sentiment35%

ZOSTAVAX®

Zoster Vaccine Live

Adult
Negative Sentiment52%

ProQuad®

Measles, Mumps, Rubella and Varicella Virus Vaccine Live

Pediatric
Negative Sentiment45%